Paper
Inhibition of microsomal drug metabolic pathways by chloramphenicol.
Published Aug 1, 1962 · Robert L. Dixon, J. R. Fouts
Biochemical pharmacology
Q1 SJR score
63
Citations
1
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
Chloramphenicol slows hexobarbital biotransformation and prolongs hypnotic action in mice by inhibiting liver microsomal drug metabolism pathways, potentially noncompetitive and irreversible.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Full text analysis coming soon...
References
Enzymatic hydroxylation of aromatic compounds.
An enzymatic aromatic hydroxylating system in liver microsomes produces phenolic metabolites from substrates, requiring TPNH and oxygen for activity.
1961·234citations·C. Mitoma et al.·Archives of biochemistry and biophysics
Archives of biochemistry and biophysics
THE EFFECT OF OBSTRUCTIVE JAUNDICE ON DRUG METABOLISM IN RABBITS
Obstructive jaundice in rabbits affects liver microsomal drug metabolism in proportion to the degree of cell damage, with mild damage retaining normal hexobarbital metabolism and severe damage leading to nearly complete loss of drug enzyme activities.
1961·87citations·Edwin F. McLuen et al.·The Journal of Pharmacology and Experimental Therapeutics
The Journal of Pharmacology and Experimental Therapeutics
On the mechanism of drug potentiation by iproniazid (2-isopropyl-1-isonicotinyl hydrazine).
Iproniazid potentiates hexobarbital's hypnotic activity by inhibiting its metabolism, similar to the effects of SKF 525-A and Lilly 18947.
1956·72citations·J. Fouts et al.·The Journal of pharmacology and experimental therapeutics
The Journal of pharmacology and experimental therapeutics
The effects of drugs on enzyme systems.
Drug-enzyme interactions are complex and diverse, and rational drug development remains a challenge in the face of this complexity.
1956·57citations·F. E. Hunter et al.·Pharmacological reviews
Pharmacological reviews
Inhibition of drug metabolic pathways by the potentiating agent, 2, 4-dichloro-6-phenyl-phenoxyethyl diethylamine.
Lilly 18947 prolongs hypnotic activity of hexobarbital by inhibiting its biotransformation, potentially acting by a similar mechanism to the SKF compounds.
1955·51citations·J. Fouts et al.·The Journal of pharmacology and experimental therapeutics
The Journal of pharmacology and experimental therapeutics
Citations
Chloramphenicol-Wirkungen auf Enzymsysteme innerhalb des Arzneimittelabbaus
Chloramphenicol, a broad-spectrum antibiotic, can prolong narcosis duration by enzymatic breakdown, slow down local anesthetic degradation, and reduce the toxicity of insecticide parathion (E 605).
2010·1citation·H. Hapke et al.·Journal of Veterinary Medicine Series A-physiology Pathology Clinical Medicine
Journal of Veterinary Medicine Series A-physiology Pathology Clinical Medicine
Beitrag zur Pharmakokinetik von Chloramphenicol und Tylosin in Kombinationspräparaten
Chloramphenicol significantly slows down tylosin elimination in rats and 3-day-old calves, with a significant dependence on animal maturity.
2010·0citations·M. Kietzmann et al.·Journal of Veterinary Medicine Series A-physiology Pathology Clinical Medicine
Journal of Veterinary Medicine Series A-physiology Pathology Clinical Medicine
The effect of chloramphenicol on hepatic biotransformation enzyme activity and on the duration of pentobarbital or ketamine/xylazine anesthesia in guinea pigs (Cavia porcellus).
Chloramphenicol decreases liver enzyme activity but does not prolong anesthesia duration in guinea pigs, unlike dogs, cats, rats, and mice.
2009·2citations·A. P. Crnić et al.·Veterinarski Arhiv
Veterinarski Arhiv
Methyl mercury decomposition in mice treated with antibiotics.
Antibiotics reduce intestinal microorganisms, leading to reduced methyl mercury decomposition and faecal excretion in mice.
2009·29citations·Y. Seko et al.·Acta pharmacologica et toxicologica
Acta pharmacologica et toxicologica
Hepatotoxicity associated with pharmacologic agents in dogs and cats.
Pharmacologic agents can cause hepatotoxicity in dogs and cats, with recent examples including diethylcarbamazine/oxibendazole, phenobarbital, and trirnethoprirnlsulfadiazine.
1993·34citations·Susan E. Bunch·The Veterinary clinics of North America. Small animal practice
The Veterinary clinics of North America. Small animal practice
The role of epoxidation in 4-vinylcyclohexene-induced ovarian toxicity.
VCH-induced ovarian tumors in mice involve metabolism to epoxides and oocyte destruction, while rats may be resistant due to insufficient conversion to epoxides.
1990·118citations·Bill J. Smith et al.·Toxicology and applied pharmacology
Toxicology and applied pharmacology
Cocaine-induced changes in perfusion pressure and bile flow in perfused rat livers.
Cocaine increases perfusion pressure in the liver, decreases bile flow, and reduces oxygen uptake, without relying on alpha-receptor activation or prostaglandins.
1989·6citations·C. Garhart et al.·Biochemical pharmacology
Biochemical pharmacology
Effects of phenobarbital, chlordane, and oxytetracycline on DDT excretion in rats.
Phenobarbital and chlordane increase biliary excretion of DDT in rats, while oxytetracycline increases biliary flow but does not affect DDT excretion.
1986·1citation·F. R. Puga et al.·Ecotoxicology and environmental safety
Ecotoxicology and environmental safety